IL11 and bone cancer: There were a number of reports that documented the involvement of IL-11 in various malignancies including gastric, colorectal, pancreatic, prostate, breast, ovarian, endometrial, and bone cancers, and some studies have been published on targeting IL-11 signaling in preclinical models of cancer (50).